University of Lille

News and Video Search Results

News coverage

BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million

GlobeNewswire 07 May 2024

· *Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of..

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
GlobeNewswire 17 Apr 2024
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
GlobeNewswire 21 Feb 2024
Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications
GlobeNewswire 19 Jan 2024
Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant
GlobeNewswire 07 Dec 2023

0 shares 1 views

You might like

University of Lille media coverage

GENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+™ as a Screening Tool for the Enrollment of Patients in MASH Clinical Trials

GlobeNewswire 06 Dec 2023

· *The paper published in **Journal of Hepatology** demonstrates that NIS2+™ technology could significantly reduce liver biopsy..

GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
GlobeNewswire 16 Nov 2023
Olfa Hamdi Announces 2024 Presidential Campaign in Tunisia
Accesswire 13 Nov 2023
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023
GlobeNewswire 02 Nov 2023
Carbios Places Sustainability at the Heart of its Governance with New Appointment to its Executive Committee
EQS Group 23 Oct 2023

Advertisement

More coverage

GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology

GlobeNewswire 26 Sep 2023

*Lille **(**France**)**; Cambridge **(**Massachusetts, **United States)**;** Zurich (Switzerland**);* *September* *2**6**,**..

Guerbet: Changes in Guerbet's Board of Directors
GlobeNewswire 26 May 2023
GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology
GlobeNewswire 23 May 2023
Amerant Bank Names Caroline Vérot Moore Houston Market President
GlobeNewswire 18 Apr 2023
AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis
GlobeNewswire 29 Dec 2022